BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8275416)

  • 1. Survival trend after invasive cervical cancer diagnosis in Sweden before and after cytologic screening. 1960-1984.
    Adami HO; Pontén J; Sparén P; Bergström R; Gustafsson L; Friberg LG
    Cancer; 1994 Jan; 73(1):140-7. PubMed ID: 8275416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved control of invasive cervical cancer in Sweden over six decades by earlier clinical detection and better treatment.
    Sparén P; Gustafsson L; Friberg LG; Pontén J; Bergström R; Adami HO
    J Clin Oncol; 1995 Mar; 13(3):715-25. PubMed ID: 7884431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of preinvasive cancer of the cervix and the subsequent reduction in invasive cancer.
    Bergström R; Adami HO; Gustafsson L; Pontén J; Sparén P
    J Natl Cancer Inst; 1993 Jul; 85(13):1050-7. PubMed ID: 8515491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advancing age and cervical cancer screening and prognosis.
    Sawaya GF; Sung HY; Kearney KA; Miller M; Kinney W; Hiatt RA; Mandelblatt J
    J Am Geriatr Soc; 2001 Nov; 49(11):1499-504. PubMed ID: 11890589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytologic screening for cancer of the uterine cervix in Sweden evaluated by identification and simulation.
    Gustafsson L; Adami HO
    Br J Cancer; 1990 Jun; 61(6):903-8. PubMed ID: 2372495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening and cervical cancer cure: population based cohort study.
    Andrae B; Andersson TM; Lambert PC; Kemetli L; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S; Sparén P
    BMJ; 2012 Mar; 344():e900. PubMed ID: 22381677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-risk human papillomavirus status and prognosis in invasive cervical cancer: A nationwide cohort study.
    Lei J; Ploner A; Lagheden C; Eklund C; Nordqvist Kleppe S; Andrae B; Elfström KM; Dillner J; Sparén P; Sundström K
    PLoS Med; 2018 Oct; 15(10):e1002666. PubMed ID: 30273338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of invasive cervical cancer after atypical glandular cells in cervical screening: nationwide cohort study.
    Wang J; Andrae B; Sundström K; Ström P; Ploner A; Elfström KM; Arnheim-Dahlström L; Dillner J; Sparén P
    BMJ; 2016 Feb; 352():i276. PubMed ID: 26869597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality of non-participants in cervical screening: Register-based cohort study.
    Dugué PA; Lynge E; Rebolj M
    Int J Cancer; 2014 Jun; 134(11):2674-82. PubMed ID: 24288241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variations in survival for invasive cervical cancer among European women, 1978-89. EUROCARE Working Group.
    Gatta G; Capocaccia R; Hakulinen T; Sant M; Verdecchia A; De Angelis G; Micheli A; Berrino F
    Cancer Causes Control; 1999 Dec; 10(6):575-81. PubMed ID: 10616826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for cancer of the cervix in elderly women.
    Fletcher A
    Lancet; 1990 Jan; 335(8681):97-9. PubMed ID: 1967429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of cervical screening after age 60 years according to screening history: Nationwide cohort study in Sweden.
    Wang J; Andrae B; Sundström K; Ploner A; Ström P; Elfström KM; Dillner J; Sparén P
    PLoS Med; 2017 Oct; 14(10):e1002414. PubMed ID: 29065127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
    Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
    J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In situ and invasive cervical cancer epidemiology in the province of Girona, Spain 1990-2004: incidence, mortality, survival and screening history].
    Castro Marqueta P; Moreno-Crespi J; Buxó-Pujolràs M; Cervantes-Amat M; Pérez-Gómez B; Marcos-Gragera R
    Med Clin (Barc); 2011 Feb; 136(5):192-8. PubMed ID: 21051058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the effect of Papanicolaou screening in Sweden: record linkage between a central screening registry and the National Cancer Registry.
    Pettersson F; Näslund I; Malker B
    IARC Sci Publ; 1986; (76):91-105. PubMed ID: 3570419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Success of a cervical cancer screening program: trends in incidence in songkhla, southern Thailand, 1989-2010, and prediction of future incidences to 2030.
    Sriplung H; Singkham P; Iamsirithaworn S; Jiraphongsa C; Bilheem S
    Asian Pac J Cancer Prev; 2014; 15(22):10003-8. PubMed ID: 25520060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elderly women above screening age diagnosed with cervical cancer have a worse prognosis.
    Darlin L; Borgfeldt C; Widén E; Kannisto P
    Anticancer Res; 2014 Sep; 34(9):5147-51. PubMed ID: 25202106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytologic screening and rescreening in detection and prevention of preclinical cervical cancer.
    Lindberg LG; Ahlgren M; Nordqvist SR
    Gynecol Oncol; 1977 Jun; 5(2):121-33. PubMed ID: 881124
    [No Abstract]   [Full Text] [Related]  

  • 19. Invasive cervical cancer in a cytologically screened population.
    Bjerre B; Johansson S
    Acta Obstet Gynecol Scand; 1983; 62(6):569-74. PubMed ID: 6670463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. About invasive cervical cancer: a French population based study between 1998 and 2010.
    Lorin L; Bertaut A; Hudry D; Beltjens F; Roignot P; Bone-Lepinoy MC; Douvier S; Arveux P
    Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():1-6. PubMed ID: 26004674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.